These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36822216)

  • 21. The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
    Essegian D; Khurana R; Stathias V; Schürer SC
    Cell Rep Med; 2020 Oct; 1(7):100128. PubMed ID: 33205077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling.
    Hou DX; Kumamoto T
    Antioxid Redox Signal; 2010 Sep; 13(5):691-719. PubMed ID: 20070239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
    Cowan-Jacob SW; Jahnke W; Knapp S
    Future Med Chem; 2014 Apr; 6(5):541-61. PubMed ID: 24649957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the roles of protein kinases using chemical genetics.
    Elphick LM; Lee SE; Anderson AA; Child ES; Bonnac L; Gouverneur V; Mann DJ
    Future Med Chem; 2009 Oct; 1(7):1233-41. PubMed ID: 21426100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome.
    Wilson LJ; Linley A; Hammond DE; Hood FE; Coulson JM; MacEwan DJ; Ross SJ; Slupsky JR; Smith PD; Eyers PA; Prior IA
    Cancer Res; 2018 Jan; 78(1):15-29. PubMed ID: 29254998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule kinase inhibitors as anti-cancer therapeutics.
    Chahrour O; Cairns D; Omran Z
    Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods in Enzymology. Protein kinase inhibitors in research and medicine. Preface.
    Shokat KM
    Methods Enzymol; 2014; 548():xi-xii. PubMed ID: 25399648
    [No Abstract]   [Full Text] [Related]  

  • 29. Catalytic mechanisms and regulation of protein kinases.
    Wang Z; Cole PA
    Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases.
    Persky NS; Hernandez D; Do Carmo M; Brenan L; Cohen O; Kitajima S; Nayar U; Walker A; Pantel S; Lee Y; Cordova J; Sathappa M; Zhu C; Hayes TK; Ram P; Pancholi P; Mikkelsen TS; Barbie DA; Yang X; Haq R; Piccioni F; Root DE; Johannessen CM
    Nat Struct Mol Biol; 2020 Jan; 27(1):92-104. PubMed ID: 31925410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
    Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
    Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques.
    Lapins M; Wikberg JE
    BMC Bioinformatics; 2010 Jun; 11():339. PubMed ID: 20569422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mammalian target of rapamycin kinase and tumor growth inhibition.
    Boulay A; Lane HA
    Recent Results Cancer Res; 2007; 172():99-124. PubMed ID: 17607938
    [No Abstract]   [Full Text] [Related]  

  • 35. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
    Bailey FP; Andreev VI; Eyers PA
    Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening.
    Brylinski M; Skolnick J
    J Chem Inf Model; 2010 Oct; 50(10):1839-54. PubMed ID: 20853887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosensors for Screening Kinase Inhibitors.
    Bhalla N; Estrela P
    Curr Top Med Chem; 2017; 17(22):2470-2481. PubMed ID: 28558640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective.
    Li YH; Wang PP; Li XX; Yu CY; Yang H; Zhou J; Xue WW; Tan J; Zhu F
    PLoS One; 2016; 11(11):e0165737. PubMed ID: 27828998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance.
    Klüter S; Simard JR; Rode HB; Grütter C; Pawar V; Raaijmakers HC; Barf TA; Rabiller M; van Otterlo WA; Rauh D
    Chembiochem; 2010 Dec; 11(18):2557-66. PubMed ID: 21080395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.